Suchergebnisse
EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
ZETA's Path to Profitability: Sustainable or a Mere One-Time Event?
Zeta Global ZETA reported its 18th consecutive “beat and raise” quarter in its fourth-quarter 2025 earnings release. The primary point of interest was $6.5 million in net income, accompanied by a
EGHT vs. FFIV: Which Stock Is the Better Value Option?
Investors interested in stocks from the Internet - Software sector have probably already heard of 8x8 (EGHT) and F5 Networks (FFIV). But which of these two stocks is more attractive to value
NTWK Q2 Earnings Grow Y/Y on Service Strength, 2026 Guidance Raised
NETSOL Technologies NTWK reported a solid second-quarter fiscal 2026, highlighted by double-digit year-over-year revenue growth, improved margins and a return to operating profitability. Strength in
Brighthouse Financial's Q4 Earnings & Revenues Miss, Expenses Rise Y/Y
Brighthouse Financial, Inc. BHF reported fourth-quarter 2025 adjusted net income of $3.93 per share, which missed the Zacks Consensus Estimate by 24.3%. The bottom line decreased 33.2% year over
CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans
Cytokinetics CYTK reported a net loss of $1.50 per share for the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.48. In the year-ago quarter, the company reported a
Nelnet Inc
WKN: 911438 / Name: Nelnet / Aktie / Kommerzielle Dienstleistungen / Small Cap /